Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CannaSher is an Israeli-based pharmaceutical company focused on the development of advanced cannabinoid-based therapies. The company specializes in creating standardized, pharmaceutical-grade cannabis products and delivery systems designed to treat a variety of medical conditions including chronic pain and inflammation. By leveraging proprietary extraction and formulation technologies, CannaSher aims to bridge the gap between traditional herbal cannabis and modern clinical medicine. Their research focuses on optimizing the therapeutic ratio of phytocannabinoids to improve patient outcomes and minimize side effects. The company is positioned within the growing medical cannabis ecosystem in Israel, utilizing the country's robust regulatory framework for clinical research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CannaSher.